GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » FCF Yield %

Pentixapharm Holding AG (XTER:PTP) FCF Yield % : -13.41 (As of Mar. 27, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Pentixapharm Holding AG's Trailing 12-Month Free Cash Flow is €-10.86 Mil, and Market Cap is €80.96 Mil. Therefore, Pentixapharm Holding AG's FCF Yield % for today is -13.41%.

The historical rank and industry rank for Pentixapharm Holding AG's FCF Yield % or its related term are showing as below:

XTER:PTP' s FCF Yield % Range Over the Past 10 Years
Min: -13.41   Med: -3.57   Max: -2.41
Current: -13.41

During the past 3 years, the highest FCF Yield % of Pentixapharm Holding AG was -2.41%. The lowest was -13.41%. And the median was -3.57%.

XTER:PTP's FCF Yield % is ranked better than
51.33% of 1500 companies
in the Biotechnology industry
Industry Median: -14.58 vs XTER:PTP: -13.41

Pentixapharm Holding AG's FCF Margin % for the quarter that ended in Jun. 2024 was -6,794.38%.

Pentixapharm Holding AG FCF Yield % Historical Data

The historical data trend for Pentixapharm Holding AG's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pentixapharm Holding AG FCF Yield % Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23
FCF Yield %
- - -

Pentixapharm Holding AG Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
FCF Yield % - - - - -

Competitive Comparison of Pentixapharm Holding AG's FCF Yield %

For the Biotechnology subindustry, Pentixapharm Holding AG's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pentixapharm Holding AG's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pentixapharm Holding AG's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Pentixapharm Holding AG's FCF Yield % falls into.


';

Pentixapharm Holding AG FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Pentixapharm Holding AG's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2.813 / 0
=N/A%

Pentixapharm Holding AG's annualized FCF Yield % for the quarter that ended in Jun. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-6.047 * 2 / 0
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pentixapharm Holding AG FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Pentixapharm Holding AG FCF Yield % Related Terms

Thank you for viewing the detailed overview of Pentixapharm Holding AG's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pentixapharm Holding AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » FCF Yield %
Comparable Companies
XTER:HPHA STU:T9G XTER:MDG1 XTER:FYB VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270 SMMT UTHR INSM XKRX:196170 RPRX OCSE:GMAB
Traded in Other Exchanges
N/A
Address
Robert-Rossle-Street 10, Berlin, DEU
Website
https://www.pentixapharm.com
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.

Pentixapharm Holding AG Headlines

No Headlines